Klaus Mantwill

783 total citations
25 papers, 631 citations indexed

About

Klaus Mantwill is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Klaus Mantwill has authored 25 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Genetics and 15 papers in Oncology. Recurrent topics in Klaus Mantwill's work include Virus-based gene therapy research (19 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Klaus Mantwill is often cited by papers focused on Virus-based gene therapy research (19 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Klaus Mantwill collaborates with scholars based in Germany, Austria and United States. Klaus Mantwill's co-authors include Per Sonne Holm, Hermann Lage, Bernd Gänsbacher, Manfred Dietel, Roman Nawroth, Karsten Jürchott, Alexandra Bernshausen, Gabriel Glockzin, Hans‐Dieter Royer and Axel Ladhoff and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Klaus Mantwill

25 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Mantwill Germany 15 405 341 301 83 76 25 631
Ta-Jen Liu United States 7 490 1.2× 419 1.2× 353 1.2× 116 1.4× 55 0.7× 8 687
Shannon Barker United States 15 554 1.4× 597 1.8× 431 1.4× 154 1.9× 76 1.0× 20 849
X Ye China 7 401 1.0× 453 1.3× 162 0.5× 39 0.5× 108 1.4× 8 642
M. J. Uprichard United States 8 292 0.7× 323 0.9× 421 1.4× 88 1.1× 49 0.6× 18 597
Arnold Kloos Germany 14 220 0.5× 276 0.8× 408 1.4× 65 0.8× 241 3.2× 27 630
D Banerjee United States 10 348 0.9× 172 0.5× 186 0.6× 40 0.5× 74 1.0× 14 555
Jessica Wenthe Sweden 11 225 0.6× 312 0.9× 611 2.0× 82 1.0× 315 4.1× 24 799
E. Galanis United States 9 340 0.8× 430 1.3× 289 1.0× 112 1.3× 32 0.4× 17 656
J. Ironside United Kingdom 4 583 1.4× 708 2.1× 538 1.8× 180 2.2× 42 0.6× 7 916
Maxine Bauzon United States 12 303 0.7× 397 1.2× 361 1.2× 89 1.1× 77 1.0× 25 606

Countries citing papers authored by Klaus Mantwill

Since Specialization
Citations

This map shows the geographic impact of Klaus Mantwill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Mantwill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Mantwill more than expected).

Fields of papers citing papers by Klaus Mantwill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Mantwill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Mantwill. The network helps show where Klaus Mantwill may publish in the future.

Co-authorship network of co-authors of Klaus Mantwill

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Mantwill. A scholar is included among the top collaborators of Klaus Mantwill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Mantwill. Klaus Mantwill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mantwill, Klaus, Per Sonne Holm, Kristina Schwamborn, et al.. (2025). Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer. Scientific Reports. 15(1). 13443–13443. 1 indexed citations
2.
Schober, Sebastian Johannes, Melanie Thiede, Julia Hauer, et al.. (2023). The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma. Clinical Cancer Research. 29(10). 1996–2011. 14 indexed citations
3.
Mantwill, Klaus, Yuling Zhao, Christian Ploner, et al.. (2023). Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication. Journal of Virology. 97(6). e0037023–e0037023. 4 indexed citations
4.
Nguyen, Julia, et al.. (2023). Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer. Urologic Oncology Seminars and Original Investigations. 41(5). 253.e11–253.e20. 3 indexed citations
5.
Koch, J., Sebastian Johannes Schober, Klaus Mantwill, et al.. (2022). Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus. Nature Communications. 13(1). 4689–4689. 27 indexed citations
6.
Mantwill, Klaus, et al.. (2021). Concepts in Oncolytic Adenovirus Therapy. International Journal of Molecular Sciences. 22(19). 10522–10522. 68 indexed citations
7.
Koll, Florestan, Klaus Mantwill, Klaus‐Peter Janssen, et al.. (2018). The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer. Human Gene Therapy. 30(1). 44–56. 18 indexed citations
8.
Dohmen, Christian, Klaus Mantwill, Andreas Kolk, et al.. (2017). Adenovirus Particle Quantification in Cell Lysates Using Light Scattering. Human Gene Therapy Methods. 28(5). 268–276. 10 indexed citations
9.
10.
Mantwill, Klaus, Ulrike Naumann, Janina Seznec, et al.. (2013). YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells. Journal of Translational Medicine. 11(1). 216–216. 45 indexed citations
11.
Kolk, Andreas, Karin Mengele, Klaus Mantwill, et al.. (2011). Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients. British Journal of Cancer. 105(12). 1864–1873. 35 indexed citations
12.
Mantwill, Klaus, Emanuel Rognoni, Martina Anton, et al.. (2010). YB‐1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma. International Journal of Cancer. 129(5). 1265–1276. 27 indexed citations
13.
Rognoni, Emanuel, Klaus Mantwill, Bernd Gänsbacher, et al.. (2009). Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo. Cancer Gene Therapy. 16(10). 753–763. 22 indexed citations
14.
Mantwill, Klaus, Karsten Jürchott, Gabriel Glockzin, et al.. (2007). Impact of radiation therapy on the oncolytic adenovirus dl520: Implications on the treatment of glioblastoma. Radiotherapy and Oncology. 86(3). 419–427. 34 indexed citations
15.
Mantwill, Klaus, Alexandra Bernshausen, Hermann Lage, et al.. (2006). Inhibition of the Multidrug-Resistant Phenotype by Targeting YB-1 with a Conditionally Oncolytic Adenovirus: Implications for Combinatorial Treatment Regimen with Chemotherapeutic Agents. Cancer Research. 66(14). 7195–7202. 44 indexed citations
16.
Mantwill, Klaus, Alexandra Bernshausen, Gabriel Glockzin, et al.. (2006). Novel Three-Pronged Strategy to Enhance Cancer Cell Killing in Glioblastoma Cell Lines: Histone Deacetylase Inhibitor, Chemotherapy, and Oncolytic Adenovirus dl520. Human Gene Therapy. 17(1). 55–70. 38 indexed citations
17.
Mantwill, Klaus, Alexandra Bernshausen, Gabriel Glockzin, et al.. (2005). Novel Three-Pronged Strategy to Enhance Cancer Cell Killing in Glioblastoma Cell Lines: Histone Deacetylase Inhibitor, Chemotherapy, and Oncolytic Adenovirus dl520. Human Gene Therapy. 0(0). 3570597201–3570597201. 2 indexed citations
18.
Holm, Per Sonne, Stephan Bergmann, Karsten Jürchott, et al.. (2002). YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter. Journal of Biological Chemistry. 277(12). 10427–10434. 90 indexed citations
19.
Mantwill, Klaus, et al.. (2000). Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. International Journal of Cancer. 88(4). 535–546. 57 indexed citations
20.
Salmassi, Ali, et al.. (1999). Characterization of a MAb to ovarian cancer and its possible diagnostic application.. PubMed. 20(4). 289–97. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ta-Jen Liu Breakdown of academic impact, for papers by Shannon Barker Breakdown of academic impact, for papers by X Ye Breakdown of academic impact, for papers by M. J. Uprichard Breakdown of academic impact, for papers by Arnold Kloos Breakdown of academic impact, for papers by D Banerjee Breakdown of academic impact, for papers by Jessica Wenthe Breakdown of academic impact, for papers by E. Galanis Breakdown of academic impact, for papers by J. Ironside Breakdown of academic impact, for papers by Maxine Bauzon
Rankless by CCL
2026